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The sustainable use of limited resources by nature to provide target molecules with
biocatalytic reactions continues to be a role model for chemical synthesis. The applica-
tion of biocatalysts to functional group transformations is shaped by the various parallel
influences like e.g. the search for selectivity, the shift from fossil-based to biobased raw
materials and the economy of molecular transformations like atom economy and step
economy. As safety, health and environment issues are key drivers for process impro-
vements in the chemical industry, the development of reactions or pathways replacing
hazardous reagents is another major factor determining the sequence of molecular trans-
formations from raw material to product.
Biocatalyst production technologies and integrated process engineering have been
instrumental in the establishment of biocatalytic reaction steps in chemical synthesis.
The inherent properties of biocatalysts make them the privileged catalysts for highly se-
lective asymmetric molecular transformations like e.g. hydrolysis reactions, oxidation re-
actions, carbon-carbon bond formation reactions as well as molecular unit transfer reac-
tions. The universe of six enzyme classes provides a tremendous goldmine for dis-
covering improved versions of enzymes with known functions as well as for finding
completely novel enzymes. With the growing collection of biocatalytic reactions, the
retrosynthetic thinking from chemical synthesis can be applied to biocatalysis as well.
Once the feasibility of a biocatalytic reaction has been proven, up- and downscaling
experiments have been useful for engineering the most adequate process design. In the
case of the first large-scale biocatalytic Baeyer-Villiger oxidation, the debottlenecking of
the substrate feed and product recovery, final purification and overcoming thermody-
namic limitations have been essential in establishing bioprocesses with high yields of
enantiopure products. These downscaling experiments in conjunction with new analyti-
cal techniques have proven useful also in the case of asymmetric synthesis of natural
compounds. Spatial and temporal organisation of biocatalysts, reactants or products is
another interesting engineering option for biocatalytic process design.
The interdisciplinary character of the dead ends and locks between chemistry, biol-
ogy and engineering requires investigations of the interfaces. Communication across sci-
entific and technological disciplines including the value creation perspective is important
for the development of a better synthesis for the final product-in-the-bottle. Whether the
successful problem solution will come from the engineering of substrates, reaction me-
dia, process conditions or from the search for better and new enzymes, progress in the
understanding of the molecular mechanisms of enzyme action will be key for the further
development of the science of synthesis with its challenges towards the more difficult
and more complex target molecules.
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Introduction
The knowledge in the preparation of natural
and synthetic compounds has led to an enormous
number of different molecular structures for an in-
creasing number of applications. The growing hu-
man population is requiring larger amounts of prod-
ucts and intermediates, which have been and con-
tinue to be supplied by scaling up manual syntheses
from small volumes to industrial large-scale and
highly automated and controlled productions.
While the science of synthesis has contributed spec-
tacular advances in the high-yield preparation of the
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most complex molecular structures from simple
building blocks or intermediates, the applications
on industrial large-scale or in biological systems re-
mind us of the many challenges, bottlenecks and
dead ends which may be encountered on the route
from educt to product:
1) Protection of the macroenvironment (hu-
mans, environment, product) or the microenviron-
ment (other functional groups of the molecule,
other molecular components or parts of the cell)
may represent challenging tasks
2) Available known reactions may not be selec-
tive enough
3) No direct synthetic route from the starting
material to the product may be known
4) Too many steps and detours for the intended
synthetic route may be required or a key reaction
step may turn out to be a dead-end
5) Waste growth in relation to the growth of
the desired product may create problems due to un-
favourable product/waste-ratios.
Waste accumulation with each reaction step is
a common feature of production processes in chem-
ical synthesis, illustrated in Fig. 1 schematically
from starting material to product via one or more
intermediates. Therefore, increased attention to
waste is of prime importance, in addition to the tra-
ditional synthetic criteria such as product yield and
purity. If the cumulated costs of waste disposal for
each non-sustainable reaction step in Fig. 1 ap-
proach the market value of the product, waste
minimization becomes an economic necessity for
the viability of manufacturing processes worldwide.
This has led to the proposal of the Environmental
Factor (short E Factor) by Roger Sheldon1 in the
late 1980s for assessing the environmental impact
of manufacturing processes. The E factor concept
(E equals kg waste divided by kg product), as an
overall measure for the amount of waste produced
in a synthesis compared with the amount of isolated
product, has become an important parameter driv-
ing new synthetic developments.1 The economy of
a synthetic scheme on a molecular scale can be
viewed from different perspectives, but all aim at
making the best use of materials and minimizing
the waste. This is a strategy that biological cells use
with the help of nature’s catalysts in order to avoid
the scaling of waste with the increasing amount of
product as in stoichiometric reactions in chemical
synthesis. From the single reaction step perspective,
selective transformations with high atom economy
continue to be a main focus of research in the sci-
ence of synthesis.2
The attention to the overall number of steps in
a synthesis scheme aims at achieving a high step
economy by reducing the number of steps and
replacing protection-transformation-deprotection
schemes by direct transformations.3 Further waste
minimizations in synthetic schemes involve the re-
dox economy4 and reducing the use of auxiliary re-
agents and solvents in product isolations and
purifications. As waste is still accumulating with
many existing technologies at present, searching for
waste degradation to harmless compounds or for
waste conversion into new useful products contin-
ues to be relevant and may help close the path of
carbon. For producing useful compounds as well as
for converting waste into harmless or even useful
materials rather than just waste disposal, catalysis
has been and continues to be the key to economical,
energy-saving and environmentally benign chemi-
cal transformations.5,6
The early history of biocatalysis is closely re-
lated to the preparation of alcoholic beverages like
beer and wine. A scientific milestone in the 19th
century has been the theoretical concept that chemi-
cal transformations of living organisms in all forms
of life, not only microorganisms, could be related
back to the work of specific substances which
would accelerate reactions and function in a similar
way as cellular machines. The experimental discov-
ery of enzymes as these specific substances acting
like molecular machines with the ability to acceler-
ate chemical reactions in living organisms has
sparked tremendous interest until the present day
and the scientific discipline of biochemistry origi-
nated with the goal to isolate enzymes from biolog-
ical cells and determine their functioning on a mo-
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F i g . 1 – Waste accumulation from starting material to the
yield of pure product
lecular level. As enzymes within a biological cell
perform the required molecular transformations
with excellent selectivity, the waste is minimized
and product yield maximized. This is due to an
enormous amount of work that enzymes have
achieved today a remarkable success in catalyzing
useful reactions in chemical synthesis.7–10
The importance of both the molecular and en-
gineering aspects of the application of biocatalysis
in the synthesis of chemicals has already been dem-
onstrated by Louis Pasteur in 1858 in the successful
microbial resolution of racemic tartaric acid, illus-
trated in Fig. 2, combining the selective microbial
degradation of one enantiomer with the crystalliza-
tion of the remaining enantiomer.11,12 The under-
standing of biocatalysis as a key to the chemistry of
living systems and the exciting discoveries on the
molecular nature of enzyme action have paved the
way for recognizing the importance of enzymes.13
Scientific and technological progress in the
molecular and engineering sciences and their inte-
gration towards viable industrial processes has cre-
ated sustainable value by enabling a large range of
industrial biotransformations.14–16 Therefore, reac-
tion development of selected examples will be dis-
cussed in the following sections first from a molec-
ular perspective, then from an engineering perspec-
tive, and subsequently from the practical overall
perspective.
Molecular perspectives
The creation of value by converting abundant
and easily available raw materials into products of
use for the quality of life continues to be a common
goal of both nature and human societies. The mi-
cro- and macroeconomic value creation by natural
biotransformations of raw materials on our planet
has been central to life and the knowledge of the
molecular diversity of natural compounds is far
from complete. The molecular economy of bio-
catalytic transformations in nature has its counter-
part in the micro- and macroeconomic aspects of
chemical syntheses in industry, where raw material
costs, labour, energy and waste costs are related to
the atom-, step- and redox-economy of the overall
process. An area where these aspects have been
particularly pronounced, is the manufacturing of
asymmetric molecular architecture. The fascinating
asymmetry of living organisms like snails17 or the
importance of chiral molecules in the chemical and
pharmaceutical industry,18 justify the attention
given to clean manufacturing methods for products
with high stereochemical purity. The three basic ap-
proaches discovered already in the 19th century by
Louis Pasteur, involve the separation of enantio-
mers from a racemic mixture, asymmetric synthesis
by one or more stoichiometric and/or catalytic steps
and the conversion of chiral compounds from re-
newable natural raw materials. The standardization
of chirality description by the Cahn-Ingold-Prelog
rules19 and the demonstration of the enantioselec-
tive catalytic action of enzymes by John Corn-
forth20 stimulated research into the use of enzymes
for asymmetric synthesis. The inherent chirality of
enzymes due to the chirality of its amino acid con-
stituents has been applied in an ever-increasing
number of reactions for preparing molecular asym-
metry with high efficiency, enantioselectivity and
yield.7–10 The applications of different classes of en-
zymes like oxidoreductases, transferases, hydrolas-
es and lyases have been growing along various di-
rections of synthesizing enantiomerically pure
products by resolutions of racemic mixtures, asym-
metric synthesis or bioconversions from chiral nat-
ural raw materials. The high efficiency and selectiv-
ity of enzymes in catalyzing functional group trans-
formations is however not restricted to asymmetric
transformations but has been also useful for many
catalytic chemoselective conversions where no
chiral center was involved. The molecular perspec-
tive towards organic and enzymatic reactions and
the organic reaction types catalyzed by different
classes of enzymes continue to be an inspiring and
fruitful approach.21–23
Safety, health, energy and environment aspects
of chemical production technologies have become
key determinants of synthetic routes and are very
much related to the reaction design. With the in-
creasing number of enzymes becoming available,
not only can biocatalytic tools and methodologies
provide important improvements in these aspects,
but can also reduce the amount of waste.24 Even
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F i g . 2 – Resolution of racemic tartaric acid by Louis Pas-
teur 1858
more decisive reasons for the choice of a particular
biocatalytic reaction is the non-availability of the
corresponding organic reaction type, avoiding harsh
reaction conditions, which would lead to side reac-
tions, or the selective and protecting-group-free ap-
proach schematically illustrated in Fig. 3.
Biocatalytic oxidations combine the utilization
of mild oxidants like molecular oxygen, environ-
mentally friendly solvents like water and highly se-
lective and orthogonal non-stoichiometric oxidation
reactions in an ideal way with the advantages of
natural or recombinant oxidizing biocatalysts.25,26
This is an attractive alternative to classical chemical
oxidation reactions, where the simultaneous pres-
ence of reactive oxidants, flammable organic sol-
vents and toxic auxiliary reagents requires special
safety, health and environment precautions. The
prime importance of biocatalytic oxidations goes
however far beyond improvements in safety, health
and environment issues. Biocatalytic oxidation can
follow asymmetric reaction paths with remarkable
selectivity and versatility as well as improved com-
patibility with labile functional groups.26 Since the
early examples of the C5-oxidation of D-(-)-sorbi-
tol to L-(-)-sorbose catalyzed by Acetobacter sub-
oxydans in the synthesis of vitamin C27 and the
11-hydroxylation of progesterone catalyzed by
Rhizopus arrhizus in the synthesis of steroid hor-
mones,28 the use of biocatalysts in oxidation reac-
tions has been growing.25,26
The synthetic applications of oxidases are sim-
ple and therefore a variety of alcohols, amino acids,
amines, carbohydrates, metabolites, nucleosides
and other building blocks have been oxidized
enantioselectively by suitable oxidases. Among the
variety of enzymatic routes for the production of
chiral amino acids from the racemic aminoacid sub-
strates,29 the use of D- and L-specific amino-acid
oxidases has been widespread.8 The peroxides,
which are formed naturally as reaction byproducts
of the enzymatic oxidation of amino acids and often
negatively influence enzyme stability, can be easily
removed selectively by enzymatic oxidation with
catalase. The resolution of racemic m-DL-tyrosine
by immobilized D-aminoacid oxidase from Trigo-
nopsis variabilis and a subsequent Pictet-Spengler
reaction has given rapid access to enantiopure
(S)-3-carboxy-6-hydroxy-1,2,3,4-tetrahydroisoquino-
line.30 The yield can be further enhanced by
non-enantiospecific chemical reduction of the oxi-
dation product.31
With oxygen being available as abundant natu-
ral oxidant and electron acceptor, the reactions,
where one or both of the two oxygen atoms of mo-
lecular oxygen are introduced selectively into an or-
ganic substrate, are of great synthetic interest. One-
-oxygen insertion reactions into organic substrates
like hydroxylations, epoxidations, Baeyer-Villiger
oxidations, heteroatom oxidations have catalyzed a
variety of monooxygenases, with the other oxygen
atom ending up in a molecule of water.
The Baeyer-Villiger reaction has been a key
synthetic transformation for more than a century.
Since the selective oxidation of one out of several
ketone functions in an enantioselective way is a
competence of biocatalytic systems, asymmetric
Baeyer-Villiger oxidations and asymmetric hetero-
atom oxidations are best catalyzed by biocatalysts.
Baeyer-Villiger monooxygenases have been a very
useful group of enzymes due to their highly
enantioselective oxidation of linear ketones to es-
ters, cyclic ketones to lactones, N-and S-heteroatom
oxidations.32,33 The increasing number of recombi-
nant Baeyer-Villiger monooxygenases, explorations
and systematic extensions of the substrate range of
these enzymes as well as progress in the bio-
catalytic process design has significantly broadened
the range of applications for enzymatic Baeyer-Vil-
liger oxidations in organic synthesis.34–38
The selective introduction of two atoms of mo-
lecular oxygen into an organic substrate can be
achieved by a number of different reactions.
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F i g . 3 – Sustainable Functional Group Conversions from
starting material to product
Sharpless asymmetric cis-vicinal dihydroxylation
has rapidly become a most important reaction in or-
ganic chemistry. Dioxygenases as biocatalysts rep-
resent an interesting alternative26 and have been
used for the preparation of more than 300 cis-vici-
nal diols.39 The tolerance of dioxygenases like the
recombinant toluene dioxygenase and chloroben-
zene dioxygenase to other functionalities like the
nitrile group40 is of interest for the synthesis of
nitriledihydrodiols and their corresponding carb-
oxylic acids.41
The early investigations on the product stereo-
chemistry of D-sorbitol oxidation using microbes
by Tadeus Reichstein27 and ketone reduction using
dehydrogenases by Vladimir Prelog42 have inspired
the still ongoing development of numerous bio-
catalytic reactions. Dehydrogenases and ketoreduc-
tases have therefore become excellent tools for syn-
thesizing chiral alcohols,43 hydroxy aldehydes,44,45
hydroxy acids and amino acids, both in the oxida-
tion and the reduction direction.46,47
The simple availability, preparation and appli-
cation of hydrolases like acylases, proteases, ester-
ases and lipases has been instrumental in the early
introduction of enzymatic methods in organic
chemistry. The growing number of applications for
pig liver hydrolases as practical biocatalyst for
asymmetric hydrolysis reactions in more than 100
years48,49 are an illustration of the straightforward
integration of this biocatalytic methodology into
standard chemical synthesis. In addition to hydro-
lytic kinetic resolutions of racemic esters, hydrolas-
es have been excellent chiral catalysts for enantio-
selective desymmetrization of meso- and prochiral
esters by elimination of symmetry elements pre-
cluding chirality.50 Acids, alcohols, amines, lac-
tones, amino acids and other chiral building blocks
are among the products most often prepared.
Epoxide hydrolases51–53 have been used for
the preparation of chiral diols and epoxides54,55
by hydrolytic kinetic resolution of racemic epoxi-
des or by enantioselective desymmetrization of
meso-epoxides.
Nitrilases have attracted considerable synthetic
interest for the direct, mild and selective conversion
of nitrile functional groups to carboxylic acids,56
because nitrilase-catalyzed reactions avoid the
usual harsh chemical reaction conditions of strong
acids and bases at high temperature and therefore
preserve labile functional groups. Nitrilases have
also been used for the synthesis of chiral carboxylic
acids and nitriles by hydrolytic kinetic resolution of
racemic nitriles57 or by enantioselective desymmetri-
zation of prochiral dinitriles.58
The increasing structural and functional char-
acterization of transferases has also raised the inter-
est in their utilization for a diverse range of syn-
thetic reactions. Transfer reactions of the hydroxy-
acetyl-group from a variety of ketol donors to a
broad range of (2R)-hydroxyaldehydes can be cata-
lyzed efficiently by transketolases with full stereo-
control and high conversion yields. Transketo-
lase-catalyzed two-carbon chain extensions using
the irreversible ketol donor -hydroxypyruvate
have been important for the stereoselective synthe-
sis of 2-keto-(3S,4R)-diols.59–62
One area where selective biocatalytic transfer
reactions have a tremendous influence on the
E factor is the synthesis of carbohydrates and
glycocojugates, because classical chemical synthe-
sis using protection-deprotection schemes for each
glycosidic bond generates waste in stoichiometric
amounts. The large-scale preparation of highly spe-
cific natural and recombinant glycosyltransferases
for synthetic applications and the corresponding
NDP-sugar donors have been instrumental for es-
tablishing highly efficient biocatalytic glycosyla-
tions. Rapid and complete regio- and stereo-
selective glycosylations can be achieved in water
without the detour of protecting other functional
groups and solving solubility problems.63,64
Transfer reactions involving the formal transfer
of the amino group from a donor to a ketone or al-
dehyde acceptor have been known for more than 60
years and the excellent selectivity of recombinant
aminotransferases is finding practical applications
for the synthesis of both chiral and non-chiral
amines.65,66
The admirable molecular diversity of nature’s
diverse donors to be transferred to various accep-
tors in reactions catalyzed by transferases as the
ones mentioned above and others like carboxylases,
methyl- and prenyltransferases, sulfo- and phospho-
transferases is of both fundamental and practical in-
terest.
The use of lyases in the formation of new car-
bon-carbon bonds for constructing complex struc-
tures from simple building blocks is promising, be-
cause their atom and step economy can be im-
proved. Aldolase-catalyzed synthesis of lactols and
N-polyhydroxylated compounds and their subse-
quent conversion to the correspondding products
has been performed in a highly diastereoselective
manner.67–70
Molecules of increasing complexity can be
built by multi-step enzyme conversions in one-pot
or by multiple enzymes expressed in one cell. This
is of practical industrial interest in the synthesis of
compounds, where the chemical total synthesis is
not competitive.71 Robust processes to obtain the
desired complex compound require however the de-
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velopment of advanced analytical in-process con-
trols.72
Shifting the molecular perspective from the re-
action type to the product types, biocatalysts have
not only been applied for the synthesis of small mo-
lecular weight compounds, but also as catalysts for
polycondensations, ring-opening polymerizations,
oxidative polymerizations and polymer modifica-
tions.73 Polyphenols, polyanilines and vinyl poly-
mers have been prepared by oxidoreductase-cata-
lyzed oxidative polymerization, while polysaccha-
rides, cyclic oligosaccharides and polyesters have
been obtained by transferase-catalyzed polymer
synthesis. Hydrolase-catalyzed polycondensations
or ring-opening polymerizations have been used for
the preparation of polyesters, polycarbonates, poly-
amides, polyphosphates and polythioesters.
Engineering perspectives
The value creation process is not complete
with the discovery of a new bioconversion from a
starting material to the product. The development
of a suitable industrial process involves upstream
technologies, the actual bioconversion and down-
stream processing like product recovery and purifi-
cation, all of which can have a significant influence
on the final design of the overall process. Process
analysis, process design and improvement of equip-
ment, processes and their operation aiming at pro-
cess intensification play a key role for manufactur-
ing products at industrial scale. Sustainable process
engineering for the production of larger amounts of
product can be achieved in different ways, as
shown in Fig. 4, either by engineering larger reac-
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F i g . 4 – Sustainable Process Design from starting material to product
tors and equipment or by parallelization of the same
reactor and equipment size. Reduced material re-
quirements and increased speed of process develop-
ment for classical reaction scale-up through reactors
and equipment of increasing size can be achieved
by microscale techniques using microwell-plates,
microbioreactors or microreactors.74–76 The appli-
cation of microreactor technology to biocatalytic
processes extends to synthesis77 and is of much in-
terest for cases where aqueous and organic two-phase
systems require efficient mixing and toxic reagents
as e.g. in the hydroxynitrile lyase-catalyzed synthe-
sis of cyanohydrins in microreactors from the corre-
sponding aldehydes and in-situ generated HCN.78
A prerequisite is the scale-up of the production
processes for the starting material as well as for the
biocatalyst. While the starting material is not con-
sidered here, the scale-up of the biocatalyst produc-
tion already requires a key decision concerning the
form of the biocatalyst to be used (isolated enzyme,
immobilized enzyme, whole cell). Other key deci-
sions include the reactor type, reaction medium, re-
action conditions, the sequence and timing of pro-
cess steps, technology and equipment for down-
stream processing and purification. The identifica-
tion of reaction and downstream processing bottle-
necks to be overcome has been essential for the de-
velopment of large-scale processes.
The scale-up of the biocatalytic Baeyer-Villiger




down-stream processing and product purification il-
lustrate the importance of the engineering aspects
and their consideration in the early phases of the
process design.79–84
While whole cells were chosen as the form of
the biocatalyst, microbial cell growth, enzyme in-
duction and biotransformation have been devised as
three separate parts, thereby allowing independent
parameter optimization. The bottleneck of substrate
and product inhibition for the Baeyer-Villiger Mono-
oxygenase has been overcome by the process de-
sign of a resin-based substrate feed and product re-
covery process (SFPR)79,81,82 or by direct substrate
feeding below the inhibitory concentration and sol-
vent extraction of the product.80 The choice of the
reactor type and specification is another key deci-
sion for which experimental data on the process and
its parameters like the required amounts and con-
centrations of biocatalyst and oxygen and the de-
gree of mixing are useful.81 Technical improve-
ments for oxygen mass transfer have been devel-
oped using sinter-metal spargers, which have been
experimentally tested. The decision for the stirred
tank reactor has been guided by the required oxy-
gen and substrate supply.83 The choice of the
reaction medium depends on the solvent compati-
bility of the biocatalyst and the influence on the
downstream and purification process steps. The
substrate and product inhibition has been overcome
by different engineering designs. The direct liq-
uid-liquid extraction of the product from a
whole-cell catalysed Baeyer-Villiger oxidation with
controlled substrate addition can lead to significant
differences in phase separation times depending on
the utilized reaction medium. In the SFPR process
design, the lactone product is obtained after
adsorber separation from the reaction mixture and a
washing step.83 The downstream processing and the
purification of the two chiral regioisomeric lac-
tones, obtained as products in a 1:1 mixture in
nearly enantiopure form (ee > 98 %) and good
yield, has been a major bottleneck. Simulated Mov-
ing Bed Chromatography has been established as
robust large-scale purification technology achieving
a tremendous reduction in solvent consumption.84
The decision whether to use whole cell bio-
catalysts or isolated functionally pure enzymes de-
pends on various parameters like the location of the
enzyme in the cell, the substrate-product transport
abilities of the cell, possible interfering side
reactions by other enzymes of the whole cells and
the type of biocatalyst or biocatalytic reaction. Pro-
cess simplification is therefore another major pro-
cess design goal in order to allow the use of exist-
ing industrial large-scale equipment and process
control.85,86 The simple reactor configurations, used
in large-scale chemical synthesis, have been a
major factor for the success of hydrolase-catalyzed
processes at large scale.14–16,87 In case of the iso-
lated enzymes operational stability, mass transport,
separation and cost issues are important for reaction
engineering. The retention of enzymes within the
reaction space by membranes has been well estab-
lished in the operation of fed-batch or continuous
biocatalytic processes at a production scale of
several hundred tons per year.88 Production pro-
cesses using immobilized enzymes89 are also well
established and the most adequate immobiliza-
tion method can be selected from a variety of op-
tions.90
An ideal product recovery scheme would be
based on an ideal bioprocess with complete conver-
sion to a single product, so that no product-starting
material or product-side product separation would
be needed. Real product recoveries require however
a versatile toolbox of downstream technologies
to meet the demand for high-yield processes with
minimum amount of work, energy and number of
steps.
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Value creation by integrated processes
The number of reaction steps, as well as prod-
uct recovery and purification steps in-between, to-
gether with the yield, raw material and labour costs,
is among the main factors determining the econom-
ics of an overall synthesis. It is therefore clear that
the replacement of multiple downstream processing
steps or multiple reaction steps by single-stage pro-
cesses can improve operational efficiency and cost
issues. Integration of process steps can also be done
between a reaction and a downstream processing
step, as Louis Pasteur has already demonstrated in
the biocatalytic tartaric acid resolution process.11,12
In a one-step reaction, the integration should not
add new problems but simplify the overall process
and make it better scalable and more robust so that
small deviations do not lead to a failed reaction. For
a two or multi-step reaction, a sequence of reactions
steps would ideally be integrated into a single step.
If this were not possible, one option would be to
make the optimum conditions for each of the reac-
tions compatible with each other so that the overall
reaction could be performed in one pot. In many
cases however, the biocatalytic reaction step comes
before or after a series of chemical reaction steps,
which have to be worked through one after another.
Even then, a minimum of integration is required
and the choice of the right interfaces, as e.g. infor-
mation storage, reaction medium, protecting group
chemistry and purification/separation processes, be-
tween biocatalytic and classical organic synthetic
reaction steps are important. In case of incompati-
ble reaction conditions, new enzymes with the de-
sired properties and activities may be engineered or
screened from nature. The goal of shifting thermo-
dynamic equilibria to the product side can on the
other hand justify the integration of an additional ir-
reversible reaction step or an in-situ product re-
moval/separation step. In any case, the value cre-
ation in the overall process depends on various in-
teractions between molecular and engineering as-
pects as shown in Fig. 5 and the further exploration
of this exciting area looks promising.
Outlook
Biocatalysts, as nature’s privileged catalysts for
achieving high-performance transformations in liv-
ing biological systems with the resources and en-
ergy available, are a good choice for developing se-
lective chemical reactions with similar high molec-
ular economy and efficiency without negative ef-
fects on biological systems. This is of industrial in-
terest not only because of cost savings, but also be-
cause of safety, health, waste minimization, re-
source and energy efficiency. The requirement for
selective transformations and the reduction in the
extensive use of protective groups during the total
synthesis of multifunctional molecules is clearly fa-
vourable for biocatalytic reactions.
The steady progress in building biocatalytic
single-step reaction platforms, which are modular
and scalable,24 enables the evaluation of the com-
patibility with the development of chemical reac-
tion steps.91 Although thousands of new bio-
catalysts have been discovered and characterized
over the last 50 years, the continued search and de-
velopment of novel enzyme functions is key for
new or improved synthetic methodologies,92 espe-
cially where direct organic reactions are difficult or
unknown. The tremendous progress in genomics
and proteomics with the rapid sequencing technol-
ogy are providing access to a huge amount of struc-
tural information, while the functional assignments
have not kept up the same pace. The further devel-
opment of robust, reliable and meaningful func-
tional enzyme assays and analytical technologies
for biocatalytic reactions is therefore essential
for the discovery and optimization of novel bio-
catalysts or proteins with unknown functions.93 It
can be expected that the value of standardized func-
tional information and EC numbers for novel en-
zymes, standardized reporting of biocatalytic reac-
tions and rapid access will facilitate advanced
studies building on these standardizations.94
It is worthwhile for the synthesis of small mol-
ecules to perform the comparison of different meth-
ods like total chemical synthesis, chemoenzymatic
and enzymatic synthesis and engineering microbial
cell factories on each individual target. Neverthe-
less, some general issues concerning safety, health,
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F i g . 5 – The interconnection of molecular and engineering
aspects in the overall process
economic and environmental sustainability and
global boundary conditions of supply and demand,
costs and availability of raw materials, labor and
energy indicate the benefits of an increased applica-
tion of biocatalysis in organic chemistry. While to-
tal chemical synthesis is reaching out to prepare
compounds of ever increasing complexity, in the
required amounts not yet available from nature,
chemoenzymatic and enzymatic synthesis will con-
tinue its growth in new enzyme reactions as well as
in the established reaction platforms for green
large-scale manufacturing. The biological synthesis
of valuable small molecules is focusing more on the
construction and optimization of enzymatic path-
ways by metabolic engineering and synthetic biol-
ogy.95–101 The molecular aspects of the science of
synthesis will benefit from interactions between the
areas of inorganic, organic and biocatalysis. The
engineering aspects of intensifying processes, in-
creasing space-time yields, scaling issues and prod-
uct recovery will also benefit from interactions be-
tween chemical and biochemical engineering. Prog-
ress in these molecular and engineering areas will
influence the way of industrial manufacturing. Ex-
tending this perspective also to the excellent syn-
thetic performance of biological systems and the
global biosphere, the new knowledge gained at the
interface of biocatalysis and organic chemistry will
not only be useful for preparative purposes but also
for areas dealing with complex systems like sys-
tems biology.
A b b r e v i a t i o n s
CIP rules  Cahn-Ingold-Prelog rules for specifying
molecular chirality
E Factor  Environmental Factor defined as mass ratio
of waste to desired product
EC  Enzyme Commission
ISPR  in-situ product recovery
SFPR  in-situ substrate feed and product recovery
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